Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan

Toshinori Nishizawa; Torahiko Jinta; Ryosuke Koyamada; Yuki Uehara; Fumika Taki; Hiroko Arioka

doi:10.1002/jgf2.545

Journal of General and Family Medicine (Sep 2022)

Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan

Toshinori Nishizawa,
Torahiko Jinta,
Ryosuke Koyamada,
Yuki Uehara,
Fumika Taki,
Hiroko Arioka

Affiliations

Toshinori Nishizawa: Department of General Internal Medicine St. Luke's International Hospital Tokyo Japan
Torahiko Jinta: Department of Pulmonary Medicine Thoracic Center, St. Luke's International Hospital Tokyo Japan
Ryosuke Koyamada: Department of Hematology St. Luke's International Hospital Tokyo Japan
Yuki Uehara: Department of Infectious Diseases St. Luke's International Hospital Tokyo Japan
Fumika Taki: Department of Nephrology St. Luke's International Hospital Tokyo Japan
Hiroko Arioka: Department of General Internal Medicine St. Luke's International Hospital Tokyo Japan

DOI: https://doi.org/10.1002/jgf2.545
Journal volume & issue: Vol. 23, no. 5
pp. 360 – 362

Abstract

Read online

Female participants had a higher incidence of headache, nausea, myalgia, arthralgia, redness, pruritus, and inoculation site redness and pruritus (p 0.05). Low grade fever, headache, malaise, myalgia, and inoculation site induration and heat were associated with age group (p 0.05).

Published in Journal of General and Family Medicine

ISSN: 2189-7948 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/21897948

About the journal